Dermot Gildea

Dermot is the Director of Mercury's Life Sciences & Technology Business Unit. He has been a key member of Mercury for the last 25 years delivering innovative project management engineering solutions to clients across diverse industry sectors.

Dermot’s projects include the Shell Corrib Gas Terminal Project which had an estimated value of €120,000,000 and a semiconductor facility in Ireland with an estimated value €320,000,000. Other projects Dermot was heavily involved in the construction of CTC Stevenage, Intel Israel, and international pharmaceutical giant Pfizer. Dermot is an excellent communicator with strong leadership skills. His experience of managing large cross-functional teams to deliver highly complex engineering projects is a huge asset to Mercury.